View graph of relations
  1. 2005
  2. Published
    Pierik, M. J., de Hertogh, G., Vermeire, S., van Assche, G., van Eyken, P., Joossens, S., ... Geboes, K. (2005). Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's disease. Gut, 54(2), 223-227. https://doi.org/10.1136/gut.2004.042572
  3. Published
  4. 2007
  5. Published
  6. Published
    Ferrante, M., Henckaerts, L., Joossens, M., Pierik, M. J., Joossens, S., Dotan, N., ... Vermeire, S. (2007). New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut, 56(10), 1394-1403. https://doi.org/10.1136/gut.2006.108043
  7. Published
  8. Published
  9. 2009
  10. Published
  11. Published
    Bodelier, A. G., Heijckmann, C., Hameeteman, W., De Boer, E., Jonkers, D. M. A. E., Masclee, A. A. M., & Pierik, M. J. (2009). Bone Mineral Density in IBD: A 5-Year Follow-Up Study. Gastroenterology, 136(5), A196-A196.
  12. Published
    Bueno de Mesquita, M., Ferrante, M., Henckaerts, L., Joossens, M., Janssens, V., Hlavaty, T., ... Hoffman, I. (2009). Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease. European Journal of Pediatrics, 168(5), 575-583. https://doi.org/10.1007/s00431-008-0798-7
  13. Published
  14. 2010
  15. Published
  16. 2011
  17. Published
    Zelinkova, Z., de Haar, C., De Ridder, L., Pierik, M. J., Kuipers, E. J., Peppelenbosch, M. P., & van der Woude, C. J. (2011). High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy. Alimentary Pharmacology & Therapeutics, 33(9), 1053-1058. https://doi.org/10.1111/j.1365-2036.2011.04617.x
  18. Published
  19. Published
    Baars, J. E., Kuipers, E. J., Dijkstra, G., Hommes, D. W., de Jong, D. J., Stokkers, P. C., ... van der Woude, C. J. (2011). Malignant transformation of perianal and enterocutaneous fistulas is rare: results of 17 years of follow-up from The Netherlands. Scandinavian Journal of Gastroenterology, 46(3), 319-325. https://doi.org/10.3109/00365521.2010.536251
  20. Published
    Vos, A. C., Bakkal, N., Minnee, R. C., Casparie, M. K., de Jong, D. J., Dijkstra, G., ... Hommes, D. W. (2011). Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study. Inflammatory Bowel Diseases, 17(9), 1837-1845. https://doi.org/10.1002/ibd.21582
  21. Published
    Katsanos, K. H., Tatsioni, A., Pedersen, N., Shuhaibar, M., Ramirez, V. H., Politi, P., ... Tsianos, E. V. (2011). Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study. Journal of Crohn's & Colitis, 5(5), 430-442. https://doi.org/10.1016/j.crohns.2011.04.013
  22. Published
  23. 2012
  24. Published
  25. Published
  26. Published
  27. 2013
  28. Published
  29. Published
  30. Published
    van Schaik, F. D., Mooiweer, E., ten Have, M., Belderbos, T. D., ten Kate, F. J., Offerhaus, G. J., ... Oldenburg, B. (2013). Adenomas in Patients with Inflammatory Bowel Disease Are Associated with an Increased Risk of Advanced Neoplasia. Inflammatory Bowel Diseases, 19(2), 342-349. https://doi.org/10.1097/MIB.0b013e318286f771
  31. Published
    Flourie, B., Hagege, H., Tucat, G., Maetz, D., Hebuterne, X., Kuyvenhoven, J. P., ... Aoucheta, D. (2013). Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis. Alimentary Pharmacology & Therapeutics, 37(8), 767-775. https://doi.org/10.1111/apt.12266
  32. Published
  33. Published
  34. 2014
  35. Published
  36. Published
    van der Have, M. M., Mangen, M. J., van der Valk, M. E., Smeets, H. M., van Bodegraven, A., Dijkstra, G., ... Oldenburg, B. (2014). Effect of Aging on Healthcare Costs of Inflammatory Bowel Disease: A Glimpse into the Future. Inflammatory Bowel Diseases, 20(4), 637-645. https://doi.org/10.1097/01.MIB.0000442677.55051.03
  37. Published
  38. Published
    van der Valk, M. E., Mangen, M. J., Leenders, M., Dijkstra, G., van Bodegraven, A. A., Fidder, H. H., ... Oldenburg, B. (2014). Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study. Gut, 63(1), 72-79. https://doi.org/10.1136/gutjnl-2012-303376
  39. Published
  40. Published
  41. Published
    Wong, D. R., Pierik, M., Seinen, M. L., van Bodegraven, A. A., Gilissen, L. P. L., Bus, P., ... Hooymans, P. M. (2014). The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients. Journal of Crohn's & Colitis, 8(2), 120-128. https://doi.org/10.1016/j.crohns.2013.07.004
  42. Published
  43. Published
  44. Published
  45. 2015
  46. Published
    Derikx, L. A., Nissen, L. H., Drenth, J. P., van Herpen, C. M., Kievit, W., Verhoeven, R. H., ... Hoentjen, F. (2015). Better survival of renal cell carcinoma in patients with inflammatory bowel disease. Oncotarget. https://doi.org/10.18632/oncotarget.5186
  47. Published
    van der Valk, M. E., Mangen, M. J., Severs, M., ten Have, M., Dijkstra, G., van Bodegraven, A. A., ... Oldenburg, B. (2015). Comparison of Costs and Quality of Life in Ulcerative Colitis Patients with an Ileal Pouch-Anal Anastomosis, Ileostomy and Anti-TNFα Therapy. Journal of Crohn's & Colitis, 9(11), 1016-1023. https://doi.org/10.1093/ecco-jcc/jjv134
  48. Published
  49. Published
  50. Published
    Coenen, M. J., de Jong, D. J., van Marrewijk, C. J., Derijks, L. J., Vermeulen, S. H., Wong, D. R., ... Franke, B. (2015). Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease. Gastroenterology, 149(4), 907-917 e907. https://doi.org/10.1053/j.gastro.2015.06.002
  51. Published
  52. Published
    de Groof, E. J., Buskens, C. J., Ponsioen, C. Y., Dijkgraaf, M. G., D'Haens, G. R., Srivastava, N., ... Bemelman, W. A. (2015). Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial. Trials, 16(1), [366]. https://doi.org/10.1186/s13063-015-0831-x
  53. Published
  54. Published
    ten Have, M., Fidder, H. H., Leenders, M., Kaptein, A. A., van der Valk, M. E., van Bodegraven, A. A., ... Oldenburg, B. (2015). Self-reported Disability in Patients with Inflammatory Bowel Disease Largely Determined by Disease Activity and Illness Perceptions. Inflammatory Bowel Diseases, 21(2), 369-377. https://doi.org/10.1097/MIB.0000000000000278
  55. Published
  56. 2016
  57. Published
  58. Published
    Severs, M., van Erp, S. J. H., van der Valk, M. E., Mangen, M. J., Fidder, H. H., van der Have, M. M., ... Oldenburg, B. (2016). Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease. Journal of Crohn's & Colitis, 10(4), 455-461. https://doi.org/10.1093/ecco-jcc/jjv238
  59. Published
  60. Published
Previous 1 2 Next